| |
| |
|
| Insider
Information: |
Dockendorff Charles J |
| Relationship: |
Director |
| City: |
Mansfield |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
59,453 |
|
|
Indirect Shares
|
93,287 |
|
|
| Direct
Value |
$8,441,983 |
|
|
|
Indirect Value
|
$7,253,859 |
|
|
| Total
Shares |
152,740 |
|
|
| Total
Value |
$15,695,841 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -74.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Covidien Plc |
COV |
EVP & Chief Financial ... |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
|
Haemonetics Corp |
HAE |
Director |
2023-09-05 |
2,226 |
2023-09-05 |
17,915 |
Premium* |
|
|
Keysight Technologies Inc |
KEYS |
Director |
2024-03-22 |
52,754 |
2023-01-06 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2024-05-09 |
2,901 |
2024-05-09 |
60,002 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2024-03-08 |
1,572 |
2024-03-08 |
15,370 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
143 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• • – |
2015-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(110,955) |
0 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• • – |
2015-01-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(88,753) |
0 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2023-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,201 |
0 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2023-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,844 |
0 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2023-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,336 |
0 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2024-05-07 |
4 |
AS |
$72.70 |
$286,874 |
D/D |
(3,946) |
0 |
0 |
% |
|
| HOLX |
Hologic Inc |
Director |
– • – |
2017-05-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
623 |
|
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2015-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
948 |
948 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2024-01-02 |
4 |
AS |
$72.00 |
$1,153,224 |
D/D |
(16,017) |
1,465 |
0 |
% |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2024-03-08 |
4 |
AS |
$76.21 |
$111,648 |
D/D |
(1,465) |
1,572 |
0 |
% |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2023-09-05 |
4 |
AS |
$87.68 |
$895,651 |
D/D |
(10,215) |
2,226 |
0 |
% |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,747 |
2,370 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2014-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,816 |
|
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2014-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,816 |
2,816 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
2,901 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
3,037 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
3,695 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2023-08-18 |
4 |
AS |
$50.74 |
$866,631 |
D/D |
(17,079) |
3,946 |
0 |
% |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2018-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,406 |
4,776 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
5,260 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
6,725 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
7,153 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2014-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,766 |
8,766 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
• • – |
2015-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,756 |
10,522 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,990 |
11,099 |
0 |
- |
|
143 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
